These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26628298)

  • 1. Overexpression of iASPP-SV in glioma is associated with poor prognosis by promoting cell viability and antagonizing apoptosis.
    Liu X; Kang J; Liu F; Wen S; Zeng X; Liu K; Luo Y; Ji X; Zhao S
    Tumour Biol; 2016 May; 37(5):6323-30. PubMed ID: 26628298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. iASPP, a microRNA‑124 target, is aberrantly expressed in astrocytoma and regulates malignant glioma cell migration and viability.
    Liu X; Kang J; Sun S; Luo Y; Ji X; Zeng X; Zhao S
    Mol Med Rep; 2018 Jan; 17(1):1970-1978. PubMed ID: 29257240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated expression of iASPP correlates with poor prognosis and chemoresistance/radioresistance in FIGO Ib1-IIa squamous cell cervical cancer.
    Cao L; Huang Q; He J; Lu J; Xiong Y
    Cell Tissue Res; 2013 May; 352(2):361-9. PubMed ID: 23420450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoplasmic iASPP expression as a novel prognostic indicator in oral cavity squamous cell carcinoma.
    Kim JW; Roh JL; Park Y; Cho KJ; Choi SH; Nam SY; Kim SY
    Ann Surg Oncol; 2015 Feb; 22(2):662-9. PubMed ID: 25149434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of Inhibition of Apoptosis-Stimulating Protein of p53 (iASPP) Suppresses Cisplatin-Resistant Gastric Carcinoma In Vitro.
    Yu J; Li L; Huang C
    Med Sci Monit; 2017 Nov; 23():5542-5549. PubMed ID: 29161238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of lentivirus-mediated silencing of PPM1D and temozolomide chemotherapy eradicates malignant glioma through cell apoptosis and cell cycle arrest.
    Wang P; Ye JA; Hou CX; Zhou D; Zhan SQ
    Oncol Rep; 2016 Nov; 36(5):2544-2552. PubMed ID: 27633132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of iASPP Expression Suppresses Proliferation, Invasion and Increases Chemosensitivity to Paclitaxel of Head and Neck Squamous Cell Carcinoma
    Liu ZZ; Kuang WL; Zeng WJ; Xiao JY; Tian YQ
    Chin Med Sci J; 2019 Sep; 34(3):184-193. PubMed ID: 31601301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lncRNA UCA1 interacts with miR-182 to modulate glioma proliferation and migration by targeting iASPP.
    He Z; Wang Y; Huang G; Wang Q; Zhao D; Chen L
    Arch Biochem Biophys; 2017 Jun; 623-624():1-8. PubMed ID: 28137422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Long Noncoding RNA TP73-AS1 Interacted with miR-124 to Modulate Glioma Growth by Targeting Inhibitor of Apoptosis-Stimulating Protein of p53.
    Xiao S; Wang R; Wu X; Liu W; Ma S
    DNA Cell Biol; 2018 Feb; 37(2):117-125. PubMed ID: 29412778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated expression of iASPP in head and neck squamous cell carcinoma and its clinical significance.
    Liu Z; Zhang X; Huang D; Liu Y; Zhang X; Liu L; Li G; Dai Y; Tan H; Xiao J; Tian Y
    Med Oncol; 2012 Dec; 29(5):3381-8. PubMed ID: 22815155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel isoform of iASPP and its interaction with p53.
    Zhang X; Diao S; Rao Q; Xing H; Liu H; Liao X; Wang M; Wang J
    J Mol Biol; 2007 May; 368(4):1162-71. PubMed ID: 17391696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. iASPP and chemoresistance in ovarian cancers: effects on paclitaxel-mediated mitotic catastrophe.
    Jiang L; Siu MK; Wong OG; Tam KF; Lu X; Lam EW; Ngan HY; Le XF; Wong ES; Monteiro LJ; Chan HY; Cheung AN
    Clin Cancer Res; 2011 Nov; 17(21):6924-33. PubMed ID: 21926165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of iASPP-dependent aggressiveness in cervical cancer through reversal of methylation silencing of microRNA-124.
    Dong P; Xiong Y; Watari H; Hanley SJ; Konno Y; Ihira K; Suzuki F; Yamada T; Kudo M; Yue J; Sakuragi N
    Sci Rep; 2016 Oct; 6():35480. PubMed ID: 27765948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low c-Met expression levels are prognostic for and predict the benefits of temozolomide chemotherapy in malignant gliomas.
    Li MY; Yang P; Liu YW; Zhang CB; Wang KY; Wang YY; Yao K; Zhang W; Qiu XG; Li WB; Peng XX; Wang YZ; Jiang T
    Sci Rep; 2016 Feb; 6():21141. PubMed ID: 26879272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dec1 expression predicts prognosis and the response to temozolomide chemotherapy in patients with glioma.
    Li XM; Lin W; Wang J; Zhang W; Yin AA; Huang Y; Zhang J; Yao L; Bian H; Zhang J; Zhang X
    Mol Med Rep; 2016 Dec; 14(6):5626-5636. PubMed ID: 27840944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of p53-inducible gene 3 is significant for glioblastoma progression and predicts poor patient prognosis.
    Quan J; Li Y; Jin M; Chen D; Yin X; Jin M
    Tumour Biol; 2017 Mar; 39(3):1010428317694572. PubMed ID: 28351326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-expression of midkine and pleiotrophin predicts poor survival in human glioma.
    Ma J; Lang B; Wang X; Wang L; Dong Y; Hu H
    J Clin Neurosci; 2014 Nov; 21(11):1885-90. PubMed ID: 25001988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lncRNA H19 interacts with miR-140 to modulate glioma growth by targeting iASPP.
    Zhao H; Peng R; Liu Q; Liu D; Du P; Yuan J; Peng G; Liao Y
    Arch Biochem Biophys; 2016 Nov; 610():1-7. PubMed ID: 27693036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced expressions of FHL2 and iASPP predict poor prognosis in acute myeloid leukemia.
    Cheng Z; Dai Y; Pang Y; Jiao Y; Zhao H; Zhang Z; Qin T; Hu N; Zhang Y; Ke X; Chen Y; Wu D; Shi J; Fu L
    Cancer Gene Ther; 2019 Feb; 26(1-2):17-25. PubMed ID: 29910468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone acetyltransferase inhibitor II induces apoptosis in glioma cell lines via the p53 signaling pathway.
    Xu LX; Li ZH; Tao YF; Li RH; Fang F; Zhao H; Li G; Li YH; Wang J; Feng X; Pan J
    J Exp Clin Cancer Res; 2014 Dec; 33(1):108. PubMed ID: 25523932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.